Skip to main content
All lobbying clients

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Lobbying client · District of Columbia · filed 2025 to 2026

Represents the leading research-based pharmaceutical companies in the US.

$360,000 Reported spend
6 Filings counted
1 Firms hired
6 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (176429), not by name.

 Firms hired 1
 Bills named in these filings 6
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    6 filings
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    5 filings
  • S 832
    EPIC Act of 2025
    3 filings
  • S 3345
    PBM Price Transparency and Accountability Act
    2 filings
  • S 839
    Safeguarding Honest Speech Act
    2 filings
  • HR 9504
    Tax Exempt Hospital Transparency Act
    1 filing
 Reported by year 2 years
  • 2026 $120,000 2 filings
  • 2025 $240,000 4 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem